BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27109471)

  • 1. Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway.
    Yao J; Xu C; Fang Z; Li Y; Liu H; Wang Y; Xu C; Sun Y
    Biochem Biophys Res Commun; 2016 May; 474(1):213-219. PubMed ID: 27109471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR.
    Zheng L; Kang Y; Zhang L; Zou W
    Cancer Biol Ther; 2020; 21(1):34-42. PubMed ID: 31736422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.
    Yang ZG; Ma XD; He ZH; Guo YX
    Int Braz J Urol; 2017; 43(6):1060-1067. PubMed ID: 28727371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1.
    Xu B; Huang Y; Niu X; Tao T; Jiang L; Tong N; Chen S; Liu N; Zhu W; Chen M
    Prostate; 2015 Dec; 75(16):1896-903. PubMed ID: 26306811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W; Yao G; Zhou K
    J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway.
    Zheng Y; Lin ZY; Xie JJ; Jiang FN; Chen CJ; Li JX; Zhou X; Zhong WD
    Curr Mol Med; 2017; 17(3):221-229. PubMed ID: 28782483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.
    Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N
    Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer.
    Shao N; Ma G; Zhang J; Zhu W
    BMC Urol; 2018 Mar; 18(1):14. PubMed ID: 29506516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microRNA/Runx1/Runx2 network regulates prostate tumor progression from onset to adenocarcinoma in TRAMP mice.
    Farina NH; Zingiryan A; Akech JA; Callahan CJ; Lu H; Stein JL; Languino LR; Stein GS; Lian JB
    Oncotarget; 2016 Oct; 7(43):70462-70474. PubMed ID: 27634876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.
    Lee KH; Lin FC; Hsu TI; Lin JT; Guo JH; Tsai CH; Lee YC; Lee YC; Chen CL; Hsiao M; Lu PJ
    Biochim Biophys Acta; 2014 Sep; 1843(9):2055-66. PubMed ID: 24915000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.
    Zheng C; Guo K; Chen B; Wen Y; Xu Y
    Cancer Biomark; 2019; 26(2):193-202. PubMed ID: 31403941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
    Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
    Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.
    Yang Z; Chen J; Xie H; Liu T; Chen Y; Ma Z; Pei X; Yang W; Li L
    Cancer Lett; 2020 Mar; 473():118-129. PubMed ID: 31843555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of miR-556-5p promoted prostate cancer cell proliferation by suppressing PPP2R2A expression.
    Zhao W; Cao L; Zeng S; Qin H; Men T
    Biomed Pharmacother; 2015 Oct; 75():142-7. PubMed ID: 26297546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
    Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
    Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer.
    Zhang Y; Jiang F; He H; Ye J; Mao X; Guo Q; Wu SL; Zhong W; Wu CL; Lin N
    Cell Death Dis; 2018 Feb; 9(3):301. PubMed ID: 29467540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
    Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
    Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor and miR-206 regulation in prostate cancer.
    Chua FY; Adams BD
    Transcription; 2017; 8(5):313-327. PubMed ID: 28598253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.